PURPOSE: Although a pancreaticoduodenectomy (PD) has been recently regarded as a safe surgical procedure at high-volume centers, the efficacy of PD for patients 80 years of age and older is controversial. The aim of this study was to evaluate the perioperative and long-term outcomes following PD in patients 80 years of age and older. METHODS: Elderly patients 80 years of age and older who underwent PD between 2001 and 2009 were identified. The perioperative and long-term outcomes were compared with patients younger than 80 years of age. RESULTS: Of 561 total patients, 22 patients (3.9 %) were 80 years of age or older. Mortality occurred in one patient (4.5 %). Postoperative major complications (Clavien-Dindo classification ≥ grade III) occurred in six patients (27.3 %) in this group, which was significantly higher than in patients younger than 80 years of age (P = 0.008). The survival of the elderly patients undergoing PD for pancreatic cancer was significantly shorter than that for the same patient group with other diseases (median survival, 13 versus 82 months; P = 0.014). Only one elderly patient with pancreatic cancer survived more than 3 years. CONCLUSIONS: PD for pancreatic cancer in patients aged 80 and older should be carefully selected, because it is associated with a higher incidence of severe postoperative complications and a small change of long-term survival.
PURPOSE: Although a pancreaticoduodenectomy (PD) has been recently regarded as a safe surgical procedure at high-volume centers, the efficacy of PD for patients 80 years of age and older is controversial. The aim of this study was to evaluate the perioperative and long-term outcomes following PD in patients 80 years of age and older. METHODS: Elderly patients 80 years of age and older who underwent PD between 2001 and 2009 were identified. The perioperative and long-term outcomes were compared with patients younger than 80 years of age. RESULTS: Of 561 total patients, 22 patients (3.9 %) were 80 years of age or older. Mortality occurred in one patient (4.5 %). Postoperative major complications (Clavien-Dindo classification ≥ grade III) occurred in six patients (27.3 %) in this group, which was significantly higher than in patients younger than 80 years of age (P = 0.008). The survival of the elderly patients undergoing PD for pancreatic cancer was significantly shorter than that for the same patient group with other diseases (median survival, 13 versus 82 months; P = 0.014). Only one elderly patient with pancreatic cancer survived more than 3 years. CONCLUSIONS:PD for pancreatic cancer in patients aged 80 and older should be carefully selected, because it is associated with a higher incidence of severe postoperative complications and a small change of long-term survival.
Authors: Ioannis Hatzaras; Carl Schmidt; Dori Klemanski; Peter Muscarella; W Scott Melvin; E Christopher Ellison; Mark Bloomston Journal: J Am Coll Surg Date: 2011-01-12 Impact factor: 6.113
Authors: Laurent Sulpice; Michel Rayar; Pierre Nicolas D'Halluin; Yann Harnoy; Aude Merdrignac; Jean François Bretagne; Bernard Meunier; Karim Boudjema Journal: J Surg Res Date: 2012-04-21 Impact factor: 2.192
Authors: Michelle L DeOliveira; Jordan M Winter; Markus Schafer; Steven C Cunningham; John L Cameron; Charles J Yeo; Pierre-Alain Clavien Journal: Ann Surg Date: 2006-12 Impact factor: 12.969
Authors: Gauri R Varadhachary; Eric P Tamm; James L Abbruzzese; Henry Q Xiong; Christopher H Crane; Huamin Wang; Jeffrey E Lee; Peter W T Pisters; Douglas B Evans; Robert A Wolff Journal: Ann Surg Oncol Date: 2006-07-24 Impact factor: 5.344
Authors: Saboor Khan; Guido Sclabas; Kaye Reid Lombardo; Michael G Sarr; David Nagorney; Michael L Kendrick; John H Donohue; Florencia G Que; Michael B Farnell Journal: J Gastrointest Surg Date: 2010-08-17 Impact factor: 3.452
Authors: Russell C Langan; Chun-Chih Huang; Weisheng Renee Mao; Katherine Harris; Will Chapman; Charles Fehring; Kesha Oza; Patrick G Jackson; Reena Jha; Nadim Haddad; John Carroll; Jane Hanna; Ann Parker; Waddah B Al-Refaie; Lynt B Johnson Journal: Am J Surg Date: 2015-06-04 Impact factor: 2.565
Authors: Brandon C Chapman; Csaba Gajdos; Patrick Hosokawa; William Henderson; Alessandro Paniccia; Douglas M Overbey; Ana Gleisner; Richard D Schulick; Martin D McCarter; Barish H Edil Journal: Surg Endosc Date: 2017-10-24 Impact factor: 4.584